Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity.

Roy, Sreeja; Williams, Clare M; Wijesundara, Danushka K; Furuya, Yoichi

Roy, Sreeja; Williams, Clare M; Wijesundara, Danushka K; Furuya, Yoichi.

Afiliación

Roy S; Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
Williams CM; Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
Wijesundara DK; The School of Chemistry and Molecular Biosciences, The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Queensland 4072, Australia.
Furuya Y; Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.

Vaccines (Basel) ; 8(4)2020 Nov 16.

Article en En | MEDLINE | ID: mdl-33207559

Palabras clave

T cell immunogenicity; live attenuated influenza vaccine; mucosal responses; pre-existing antibodies; pre-existing immunity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Vaccines (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google